Search

David S. Romeo

Examiner (ID: 10447, Phone: (571)272-0890 , Office: P/1647 )

Most Active Art Unit
1647
Art Unit(s)
1647, 1801, 1643, 1646
Total Applications
1149
Issued Applications
531
Pending Applications
95
Abandoned Applications
523

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6534663 [patent_doc_number] => 20100204104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'FUSION PROTEINS CONTAINING TWO TGF-BETA BINDING DOMAINS OF TGF-BETA TYPE II RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/663638 [patent_app_country] => US [patent_app_date] => 2008-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 12154 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204104.pdf [firstpage_image] =>[orig_patent_app_number] => 12663638 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/663638
FUSION PROTEINS CONTAINING TWO TGF-BETA BINDING DOMAINS OF TGF-BETA TYPE II RECEPTOR Dec 23, 2008 Abandoned
Array ( [id] => 5434964 [patent_doc_number] => 20090169550 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'THERAPY OF RITUXIMAB-REFRACTORY RHEUMATOID ARTHRITIS PATIENTS' [patent_app_type] => utility [patent_app_number] => 12/339476 [patent_app_country] => US [patent_app_date] => 2008-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36426 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20090169550.pdf [firstpage_image] =>[orig_patent_app_number] => 12339476 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/339476
THERAPY OF RITUXIMAB-REFRACTORY RHEUMATOID ARTHRITIS PATIENTS Dec 18, 2008 Abandoned
Array ( [id] => 6614680 [patent_doc_number] => 20100310515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'Latency Associated Protein Construct With Aggrecanase Sensitive Cleavage Site' [patent_app_type] => utility [patent_app_number] => 12/808383 [patent_app_country] => US [patent_app_date] => 2008-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7838 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0310/20100310515.pdf [firstpage_image] =>[orig_patent_app_number] => 12808383 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/808383
Latency associated protein construct with aggrecanase sensitive cleavage site Dec 16, 2008 Issued
Array ( [id] => 8653051 [patent_doc_number] => 08372799 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-12 [patent_title] => 'Reverse protein' [patent_app_type] => utility [patent_app_number] => 12/747741 [patent_app_country] => US [patent_app_date] => 2008-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 9 [patent_no_of_words] => 5709 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12747741 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/747741
Reverse protein Dec 11, 2008 Issued
Array ( [id] => 6102574 [patent_doc_number] => 20110166067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'METHODS FOR INHIBITION OF SCARRING' [patent_app_type] => utility [patent_app_number] => 13/003760 [patent_app_country] => US [patent_app_date] => 2008-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 14515 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20110166067.pdf [firstpage_image] =>[orig_patent_app_number] => 13003760 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/003760
METHODS FOR INHIBITION OF SCARRING Dec 10, 2008 Abandoned
Array ( [id] => 5391198 [patent_doc_number] => 20090208511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'Novel method for identifying diabetic patients at increased risk for pathological complications' [patent_app_type] => utility [patent_app_number] => 12/315526 [patent_app_country] => US [patent_app_date] => 2008-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 26734 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20090208511.pdf [firstpage_image] =>[orig_patent_app_number] => 12315526 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/315526
Method for identifying diabetic patients at increased risk for pathological complications Dec 3, 2008 Issued
Array ( [id] => 6095180 [patent_doc_number] => 20110002880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'Material For Wound Healing and Skin Reconstruction' [patent_app_type] => utility [patent_app_number] => 12/746520 [patent_app_country] => US [patent_app_date] => 2008-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5750 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20110002880.pdf [firstpage_image] =>[orig_patent_app_number] => 12746520 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/746520
Material For Wound Healing and Skin Reconstruction Dec 3, 2008 Abandoned
Array ( [id] => 5277982 [patent_doc_number] => 20090130114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'WISE BINDING AGENTS AND EPITOPES' [patent_app_type] => utility [patent_app_number] => 12/275850 [patent_app_country] => US [patent_app_date] => 2008-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 28218 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20090130114.pdf [firstpage_image] =>[orig_patent_app_number] => 12275850 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/275850
Wise binding agents and epitopes Nov 20, 2008 Issued
Array ( [id] => 5575938 [patent_doc_number] => 20090143300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'Treatment of sepsis and septic shock using ghrelin and growth hormone' [patent_app_type] => utility [patent_app_number] => 12/291908 [patent_app_country] => US [patent_app_date] => 2008-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 5412 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20090143300.pdf [firstpage_image] =>[orig_patent_app_number] => 12291908 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/291908
Treatment of sepsis and septic shock using ghrelin and growth hormone Nov 13, 2008 Issued
Array ( [id] => 6596470 [patent_doc_number] => 20100292131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'BIOMARKERS AND METHODS FOR DIAGNOSING, PREDICTING AND/OR PROGNOSING SEPSIS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/742647 [patent_app_country] => US [patent_app_date] => 2008-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 15883 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20100292131.pdf [firstpage_image] =>[orig_patent_app_number] => 12742647 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/742647
BIOMARKERS AND METHODS FOR DIAGNOSING, PREDICTING AND/OR PROGNOSING SEPSIS AND USES THEREOF Nov 11, 2008 Abandoned
Array ( [id] => 8398185 [patent_doc_number] => 08268566 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-18 [patent_title] => 'Enhanced FC receptor-mediated tumor necrosis factor superfamily MRNA expression in peripheral blood leukocytes in patients with rheumatoid arthritis' [patent_app_type] => utility [patent_app_number] => 12/743220 [patent_app_country] => US [patent_app_date] => 2008-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6044 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12743220 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/743220
Enhanced FC receptor-mediated tumor necrosis factor superfamily MRNA expression in peripheral blood leukocytes in patients with rheumatoid arthritis Nov 10, 2008 Issued
Array ( [id] => 7656411 [patent_doc_number] => 20110305680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'Composition Containing Osteopontin for Differentiating Natural Killer Cell as an Active Ingredient and a Method of Differentiation Using Thereof' [patent_app_type] => utility [patent_app_number] => 12/995020 [patent_app_country] => US [patent_app_date] => 2008-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 6400 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20110305680.pdf [firstpage_image] =>[orig_patent_app_number] => 12995020 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/995020
Composition Containing Osteopontin for Differentiating Natural Killer Cell as an Active Ingredient and a Method of Differentiation Using Thereof Nov 9, 2008 Abandoned
Array ( [id] => 6236199 [patent_doc_number] => 20100267612 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'SUSTAINED RELEASE COMPOSITION CONTAINING SDF-1' [patent_app_type] => utility [patent_app_number] => 12/741694 [patent_app_country] => US [patent_app_date] => 2008-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9994 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267612.pdf [firstpage_image] =>[orig_patent_app_number] => 12741694 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/741694
Sustained release composition containing SDF-1 Nov 5, 2008 Issued
Array ( [id] => 6494985 [patent_doc_number] => 20100286042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'Medicinal Composition Containing Highly Functionalized Chimeric Protein' [patent_app_type] => utility [patent_app_number] => 12/682568 [patent_app_country] => US [patent_app_date] => 2008-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 13045 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286042.pdf [firstpage_image] =>[orig_patent_app_number] => 12682568 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/682568
Medicinal Composition Containing Highly Functionalized Chimeric Protein Oct 9, 2008 Abandoned
Array ( [id] => 5526748 [patent_doc_number] => 20090196825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-06 [patent_title] => 'CD38 AND OBESITY' [patent_app_type] => utility [patent_app_number] => 12/244546 [patent_app_country] => US [patent_app_date] => 2008-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9339 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20090196825.pdf [firstpage_image] =>[orig_patent_app_number] => 12244546 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/244546
CD38 and obesity Oct 1, 2008 Issued
Array ( [id] => 6195468 [patent_doc_number] => 20110027222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'Vaccine for the Treatment of Osteoarthritis' [patent_app_type] => utility [patent_app_number] => 12/677899 [patent_app_country] => US [patent_app_date] => 2008-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 10765 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20110027222.pdf [firstpage_image] =>[orig_patent_app_number] => 12677899 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/677899
Vaccine for the Treatment of Osteoarthritis Sep 23, 2008 Abandoned
Array ( [id] => 8675474 [patent_doc_number] => 08383587 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-26 [patent_title] => 'Prevention of allergy at weaning' [patent_app_type] => utility [patent_app_number] => 12/680083 [patent_app_country] => US [patent_app_date] => 2008-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3595 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12680083 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/680083
Prevention of allergy at weaning Sep 18, 2008 Issued
Array ( [id] => 5441353 [patent_doc_number] => 20090092992 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'Novel human dickkopf-related protein and nucleic molecules and uses therefor' [patent_app_type] => utility [patent_app_number] => 12/284121 [patent_app_country] => US [patent_app_date] => 2008-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 55517 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20090092992.pdf [firstpage_image] =>[orig_patent_app_number] => 12284121 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/284121
Novel human dickkopf-related protein and nucleic molecules and uses therefor Sep 16, 2008 Abandoned
Array ( [id] => 5434983 [patent_doc_number] => 20090169569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'APO-2L receptor agonist and CPT-11 synergism' [patent_app_type] => utility [patent_app_number] => 12/283526 [patent_app_country] => US [patent_app_date] => 2008-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 28953 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20090169569.pdf [firstpage_image] =>[orig_patent_app_number] => 12283526 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/283526
APO-2L receptor agonist and CPT-11 synergism Sep 11, 2008 Abandoned
Array ( [id] => 6601652 [patent_doc_number] => 20100322948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'Bone morphogenetic protein (BMP)-binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and use of same' [patent_app_type] => utility [patent_app_number] => 12/677054 [patent_app_country] => US [patent_app_date] => 2008-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 35168 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0322/20100322948.pdf [firstpage_image] =>[orig_patent_app_number] => 12677054 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/677054
Bone morphogenetic protein (BMP)-binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and use of same Sep 7, 2008 Abandoned
Menu